Lilly(Eli) & Co (NYSE: LLY) open the trading on Thursday, with great promise as it jumped 1.58% to $1009.38, before settling in for the price of $993.64 at the close. Taking a more long-term approach, LLY posted a 52-week range of $623.78-$1111.99.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 18.77%. Meanwhile, its Annual Earning per share during the time was 18.77%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 83.40%. This publicly-traded company’s shares outstanding now amounts to $945.84 million, simultaneously with a float of $851.21 million. The organization now has a market capitalization sitting at $954.25 billion. At the time of writing, stock’s 50-day Moving Average stood at $930.40, while the 200-day Moving Average is $813.99.
Lilly(Eli) & Co (LLY) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Lilly(Eli) & Co’s current insider ownership accounts for 9.96%, in contrast to 73.21% institutional ownership. According to the most recent insider trade that took place on Nov 25 ’25, this organization’s 10% Owner sold 15,632 shares at the rate of 1109.30, making the entire transaction reach 17,340,625 in total value, affecting insider ownership by 92,196,978. Preceding that transaction, on Nov 25 ’25, Company’s 10% Owner sold 147,061 for 1095.35, making the whole transaction’s value amount to 161,082,640. This particular insider is now the holder of 92,212,610 in total.
Lilly(Eli) & Co (LLY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 7.57 per share during the current fiscal year.
Lilly(Eli) & Co’s EPS increase for this current 12-month fiscal period is 83.40% and is forecasted to reach 32.35 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.16% through the next 5 years, which can be compared against the 18.77% growth it accomplished over the previous five years trading on the market.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Let’s observe the current performance indicators for Lilly(Eli) & Co (LLY). It’s Quick Ratio in the last reported quarter now stands at 1.24. Alongside those numbers, its PE Ratio stands at $49.92, and its Beta score is 0.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.06. Similarly, its price to free cash flow for trailing twelve months is now 102.92.
In the same vein, LLY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 20.22, a figure that is expected to reach 7.17 in the next quarter, and analysts are predicting that it will be 32.35 at the market close of one year from today.
Technical Analysis of Lilly(Eli) & Co (LLY)
[Lilly(Eli) & Co, LLY] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 15.33% While, its Average True Range was 47.93.
Raw Stochastic average of Lilly(Eli) & Co (LLY) in the period of the previous 100 days is set at 78.98%, which indicates a major rise in contrast to 23.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 28.69 that was higher than 22.92 volatility it exhibited in the past 100-days period.
